DNA and Gene Chip Market (By Application: Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others; By Product: Consumables, Instrumentation; By End-user: Academic & Government Research Institutes, Hospitals & Diagnostics Centers, Biotechnology & Pharmaceutical Companies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global DNA and gene chip market size is projected to register around USD 11.4 billion by 2026, this market is anticipated to grow with 10.5% CAGR during the forecast time period. The growth is driven by increase in medical investment on R&D.

Market Dynamics

DNA and gene chips have increased much achievement in giving high throughput abilities to thorough genome concentrates to upgrade malady information and target them. This innovation has risen as an important and promising arrangement crosswise over different parts of illness the executives. These variables have been driving the DNA and gene chips market.

Constant improvement of new apparatuses to help and upgrade dependability of DNA microarray innovation is probably going to drive this market at a noteworthy pace within a reasonable time-frame. Moreover, social insurance elements are occupied with misusing novel answers for improving and joining information created from gene chip with information produced from high throughput innovations. Commonly gainful associations between microarray engineers and pharmaceutical/biopharmaceutical organizations for speeding up of genomic and biomedical research exercises is foreseen to goad showcase development in the coming years.

Market Insights

Traditional methods for gene examination permit examination of generally little measures of qualities at once, which further accentuates on the take-up of DNA microarray innovation. DNA microarray innovation permits simultaneous examination of huge quantities of nucleic corrosive sections in a solitary trial.

Constant improvement of new apparatuses to help and upgrade dependability of DNA microarray innovation is probably going to drive this market at a noteworthy pace within a reasonable time-frame. Moreover, social insurance elements are occupied with misusing novel answers for improving and joining information created from gene chip with information produced from high throughput innovations. Commonly gainful associations between microarray engineers and pharmaceutical/biopharmaceutical organizations for speeding up of genomic and biomedical research exercises is foreseen to goad showcase development in the coming years.

Market Segmentation

Market By Application

  • Cancer Diagnosis & Treatment
  • Gene Expression
  • Genotyping
  • Genomics
  • Drug Discovery
  • Agricultural Biotechnology
  • Others

Market By Product

  • Consumables
  • Instrumentation

Market By End-user

  • Academic & Government Research Institutes
  • Hospitals & Diagnostics Centers
  • Biotechnology & Pharmaceutical Companies
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

The North America showcase caught the largest market share, for example, nearness of entrenched players, propelled informatics framework, nearness of specialists and gifted workforce, and continuous genomic R and D rehearses on a vast scale in the district.

Asia Pacific is relied upon to rise as a promising business sector, enlisting the most noteworthy CAGR over the conjecture time frame because of rising research and development demand in genomic examine. Besides, developing mindfulness with respect to hereditary tests for malady hazard evaluation and aversion is foreseen to positively affect the development of the regional market.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the DNA and gene chip are bioMérieux SA, Thermo Fisher Scientific, Inc. (Affymetrix, Inc.), Savyon Diagnostics, Agilent Technologies, Applied Micro Arrays, Illumina, Inc., HOKUTO ELECTRONICS CORPORATION, TOSHIBA, Perkin Elmer, Inc., Oxford Gene Technology, Arrayit Corporation, MYcroarray, Macrogen Inc., Greiner Bio One International GmbH, Asper Biotech, CapitalBio Corporation, and Microarrays Inc.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary